These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15985188)

  • 1. An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales.
    Roderick P; Nicholson T; Armitage A; Mehta R; Mullee M; Gerard K; Drey N; Feest T; Greenwood R; Lamping D; Townsend J
    Health Technol Assess; 2005 Jul; 9(24):1-178. PubMed ID: 15985188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical and cost evaluation of hemodialysis in renal satellite units in England and Wales.
    Roderick P; Armitage A; Nicholson T; Mehta R; Gerard K; Mullee M; Drey N; Lamping D; Feest T; Greenwood R; Townsend J
    Am J Kidney Dis; 2004 Jul; 44(1):121-31. PubMed ID: 15211445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional effects of satellite haemodialysis units on renal replacement therapy in non-urban Ontario, Canada.
    Prakash S; Austin PC; Oliver MJ; Garg AX; Blake PG; Hux JE
    Nephrol Dial Transplant; 2007 Aug; 22(8):2297-303. PubMed ID: 17412701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis and health-related quality of life of home and self-care satellite haemodialysis.
    Malmström RK; Roine RP; Heikkilä A; Räsänen P; Sintonen H; Muroma-Karttunen R; Honkanen E
    Nephrol Dial Transplant; 2008 Jun; 23(6):1990-6. PubMed ID: 18223263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.
    Berdud I; Arenas MD; Bernat A; Ramos R; Blanco A;
    Nefrologia; 2011; 31(6):664-9. PubMed ID: 22130281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The provision of renal replacement therapy for adults in England and Wales: recent trends and future directions.
    Roderick PJ; Ferris G; Feest TG
    QJM; 1998 Aug; 91(8):581-7. PubMed ID: 9893762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.
    MacLeod A; Daly C; Khan I; Vale L; Campbell M; Wallace S; Cody J; Donaldson C; Grant A
    Cochrane Database Syst Rev; 2001; (3):CD003234. PubMed ID: 11687058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of renal service provision in south and mid Wales.
    Christie S; Morgan G; Heaven M; Sandifer Q; Woerden Hv
    Public Health; 2005 Aug; 119(8):738-42. PubMed ID: 15949526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
    Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
    Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups.
    Beswick AD; Rees K; Griebsch I; Taylor FC; Burke M; West RR; Victory J; Brown J; Taylor RS; Ebrahim S
    Health Technol Assess; 2004 Oct; 8(41):iii-iv, ix-x, 1-152. PubMed ID: 15461879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients.
    Szczepura A; Westmoreland D; Vinogradova Y; Fox J; Clark M
    Health Technol Assess; 2006 Apr; 10(10):1-176. PubMed ID: 16595079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inequalities in rates of renal replacement therapy in England: does it matter who you are or where you live?
    Judge A; Caskey FJ; Welton NJ; Ansell D; Tomson CR; Roderick PJ; Ben-Shlomo Y
    Nephrol Dial Transplant; 2012 Apr; 27(4):1598-607. PubMed ID: 21878474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New adult patients starting renal replacement therapy in the UK in 2005 (chapter 3).
    Farrington K; Rao R; Gilg J; Ansell D; Feest T
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii11-29. PubMed ID: 17724040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What determines geographical variation in rates of acceptance onto renal replacement therapy in England?
    Roderick P; Clements S; Stone N; Martin D; Diamond I
    J Health Serv Res Policy; 1999 Jul; 4(3):139-46. PubMed ID: 10538878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK Renal Registry 16th annual report: chapter 14 2012 multisite dialysis access audit in England, Northern Ireland and Wales and 2011 PD one year follow-up: national and centre-specific analyses.
    Briggs V; Pitcher D; Shaw C; Fluck R; Wilkie M
    Nephron Clin Pract; 2013; 125(1-4):275-94. PubMed ID: 24662178
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.